Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v1-EN
Language English English
Date Updated 2019-11-19 2019-10-04
Drug Identification Number 02082136 02082136
Brand name GENTAMICIN(E) GENTAMICIN(E)
Common or Proper name GENTAMICIN(E) GENTAMICIN(E)
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients GENTAMICIN GENTAMICIN
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 100 mL (JB0863) 100 mL (JB0863)
ATC code J01GB J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-10-04 2019-10-04
Actual start date 2019-10-04 2019-10-04
Estimated end date 2019-11-18 2019-11-01
Actual end date 2019-11-18
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Short-dated product with November 2019 expiry available with approval provided. For questions or concerns contact Baxter customer care (1.888.719.9955). Short-dated product with November 2019 expiry available with approval provided. For questions or concerns contact Baxter customer care (1.888.719.9955).
Health Canada comments